Physician profile
Moses Albert
NPI 1740359017
$2,169.30
in general payments reported to CMS, 2019-2025
24 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $387 · 2021: $152 · 2023: $152 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $301.63 | 2019-2020 | |
| Janssen Biotech, INC. | $301.59 | 2019-2021 | |
| Encore Dermatology INC. | $219.13 | 2019 | |
| Botanix Sb INC | $165.14 | 2025 | Sofdra |
| Sientra, INC. | $127.89 | 2019 | |
| Dermavant Sciences, INC. | $127.81 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $112.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $107.70 | 2019 | |
| Pfizer INC. | $103.69 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $101.71 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $92.27 | 2019-2020 | |
| Galderma Laboratories, L.P. | $79.16 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $67.50 | 2019-2020 | |
| Lilly USA, LLC | $66.80 | 2019 | |
| Epi Health, LLC | $32.69 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $24.16 | 2019 | |
| Almirall LLC | $24.12 | 2019-2020 | |
| Arcutis Biotherapeutics, INC. | $24.10 | 2023 | |
| Taro Pharmaceuticals USA, INC. | $18.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.12 | 2020 | |
| Sensus Healthcare, INC. | $15.87 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $14.01 | 2020 | |
| Journey Medical Corporation | $13.99 | 2019 | |
| Merck Sharp & Dohme LLC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moses Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.